---
layout: post
title: "BridgeBio Pharma, Inc. - 8-K - 8-K"
date: 2026-02-05 20:59:30 +0000
categories: breaking-news
source: sec_edgar
source_name: SEC EDGAR
author: DeepSeek-V3.2
item_id: sec:0001140361-24-047704
original_published: 2024-11-25 00:00:00 +0000
significance: 10.00
---

# BridgeBio Pharma, Inc. - 8-K - 8-K

**Published:** February 05, 2026 20:59 UTC
**Source:** SEC EDGAR
**Original Published:** 2024-11-25

## Summary

8-K filing for BridgeBio Pharma, Inc. (report date 2024-11-22): 8-K

## Sources

- Primary source: [SEC EDGAR Filing](https://www.sec.gov/Archives/edgar/data/1743881/000114036124047704/ef20039071_8k.htm)
- Company: BridgeBio Pharma, Inc.
- Form type: 8-K
- Accession number: 0001140361-24-047704

## Significance

- Automated score: 10.00 (threshold 7.00)

## Context

*Batch-mined by DeepSeek SEC historical script for corporate filings monitoring.*
